First Time Loading...

Mevis Medical Solutions AG
XETRA:M3V

Watchlist Manager
Mevis Medical Solutions AG Logo
Mevis Medical Solutions AG
XETRA:M3V
Watchlist
Price: 26.4 EUR 0.76% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

There is not enough data to reliably calculate the relative value of M3V.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

M3V Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

2.6
P/S
P/S
Price to Sales
2.6
vs History
vs Industry
44
Median 3Y
3.4
Median 5Y
3.1
Industry
2.4
More Details
6.2
P/E
P/E
Price to Earnings
6.2
vs History
vs Industry
45
Median 3Y
8.5
Median 5Y
7.5
Industry
23.4
More Details
9.9
P/OCF
P/OCF
Price to OCF
9.9
vs History
vs Industry
36
Median 3Y
9.8
Median 5Y
9.7
Industry
15.5
More Details
10.2
P/FCFE
P/FCFE
Price to FCFE
10.2
vs History
vs Industry
34
Median 3Y
10.1
Median 5Y
10.1
Industry
23.2
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
vs Industry
33
Median 3Y
3.3
Median 5Y
3.2
Industry
2.3
More Details
2.1
EV/S
EV/S
Enterprise Value to Sales
2.1
vs History
vs Industry
49
Median 3Y
3
Median 5Y
2.7
Industry
2.5
More Details
2.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.1
vs History
vs Industry
69
Median 3Y
3.1
Median 5Y
2.8
Industry
5.3
More Details
5.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.9
vs History
vs Industry
44
Median 3Y
8.6
Median 5Y
7.4
Industry
12.6
More Details
6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
6
vs History
vs Industry
45
Median 3Y
8.7
Median 5Y
7.5
Industry
17.2
More Details
8
EV/OCF
EV/OCF
Enterprise Value to OCF
8
vs History
vs Industry
42
Median 3Y
7.9
Median 5Y
8.9
Industry
15.3
More Details
8.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.2
vs History
vs Industry
37
Median 3Y
8.1
Median 5Y
9.2
Industry
19.8
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
vs Industry
42
Median 3Y
2.5
Median 5Y
2.2
Industry
2
More Details

Multiples Across Competitors

M3V Competitors Multiples
Mevis Medical Solutions AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Mevis Medical Solutions AG
XETRA:M3V
48m EUR 2.6 6.2 5.9 6
US
Veeva Systems Inc
NYSE:VEEV
32.8B USD 13.9 62.4 62.3 67
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.9B AUD 81.1 170.1 117 117
US
Inspire Medical Systems Inc
NYSE:INSP
7.4B USD 11.8 -349 -184.9 -171.9
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.1 12.5 14.1
US
Doximity Inc
NYSE:DOCS
4.5B USD 9.6 32.6 21.8 23.2
SE
Sectra AB
STO:SECT B
42.6B SEK 26 100.4 -66.1 -66.1
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -21.7 25.6 272.8
US
Certara Inc
NASDAQ:CERT
2.8B USD 7.9 -50.8 46 461.6
P/E Multiple
Earnings Growth
DE
Mevis Medical Solutions AG
XETRA:M3V
Average P/E: 63.3
6.2
N/A
US
Veeva Systems Inc
NYSE:VEEV
62.4
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
170.1
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -349 N/A
JP
M3 Inc
TSE:2413
24.1
26%
US
Doximity Inc
NYSE:DOCS
32.6
79%
SE
Sectra AB
STO:SECT B
100.4
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -21.7 N/A
US
Certara Inc
NASDAQ:CERT
Negative Multiple: -50.8 N/A

See Also

Summary
M3V intrinsic value, competitors valuation, and company profile.
DCF Valuation
M3V stock valuation using Discount Cash Flow valuation method.
Relative Valuation
M3V stock valuation using valuation multiples.
Wall Street Estimates
M3V price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
M3V stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.